Skip to main content

Labcorp Q3 FY2026 results

  • LH · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$370.48−0.49%Close 13 Nov 2026 · Market value $30.04B

Labcorp reported revenue of $3.81 billion, up 6.9% from a year earlier, net income of $263 million and diluted earnings per share of $3.22 against $3.12 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).

From its quarterly report, the results first announced on 28 Oct 2026. Compiled and checked by AapWire.

Q3 FY2026 against Q3 FY2025

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

Labcorp Q3 FY2026 results against the year-ago quarter
MeasureQ3 FY2026Q3 FY2025Change
Revenue$3.81B$3.56B+6.9%
Gross profit$1.11B$1.03B+8.1%
Gross margin29.1%28.8%+0.3 pts
Operating income$402.1M$396.6M+1.4%
Operating margin10.6%11.1%−0.6 pts
Net income$262.8M$261.1M+0.7%
Diluted EPS$3.22$3.12+3.2%
Operating cash flow$563.8M$387.2M+45.6%
Capital expenditure$151.6M$106.7M+42.1%
Free cash flow$412.2M$280.5M+47.0%

Operating KPIs for the quarter

Labcorp operating KPIs, Q3 FY2026
KPIQ3 FY2026Change on a year
Diagnostics revenue$2.9Bup 6.5%
Biopharma Laboratory Services revenue$866.7Mup 8.5%

Earlier quarters

Labcorp results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q3 FY202630 Sep 2026$3.81B+6.9%$3.22
Q2 FY202630 Jun 2026$3.73B+5.8%$3.64
Q1 FY202631 Mar 2026$3.54B+5.8%$3.35
Q4 FY202531 Dec 2025$3.52B+5.6%$1.98
Q3 FY202530 Sep 2025$3.56B+8.6%$3.12
Q2 FY202530 Jun 2025$3.53B+9.5%$2.84
Q1 FY202531 Mar 2025$3.35B+5.3%$2.52
Q4 FY202431 Dec 2024$3.33B+9.8%$1.71

More on Labcorp: financial statements · revenue · earnings per share

LH's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.